Data / Form D filings / AMORPHEX THERAPEUTICS HOLDINGS INC.
AMORPHEX THERAPEUTICS HOLDINGS INC.: Form D filing
AMORPHEX THERAPEUTICS HOLDINGS INC., a pharmaceuticals company in Andover, MA, filed a Form D with the SEC in 2023. The latest, on January 20, 2023, reports $265,000 sold of a $265,000 offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 DUNDEE PARK, SUITE 8, Andover, MA, 01810
- Phone
- (978) 244-4990
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1962460
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 20, 2023 | New notice | $265,000 | $265,000 | 13 | Nov 26, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| ROBERT THOMPSON | Executive Officer, Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jan 16, 2023 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what AMORPHEX THERAPEUTICS HOLDINGS INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.